Thus, a child who has not been dry for more than 6 months previously without any bladder dysfunction is considered to have primary
monosymptomatic nocturnal enuresis (MNE).
Prevalence and risk factors of monosymptomatic nocturnal enuresis in Turkish children.
The distributions of voiding dysfunction, nocturnal enuresis and monosymptomatic nocturnal enuresis prevalence among age groups in our study Age n VD %, (n) NE %, (n) Monosymptomatic (year) NE %, (n) 7 358 13.1 (47) 14.5 (52) 5.9 (21) 8 465 10.5 (49) 9.9 (46) 4.7 (22) 9 489 9.0 (44) 7.8 (38) 3.1 (15) 10 398 7 (28) 5.5 (22) 1.8 (7) 11 412 4.4 (18) 4.1 (17) 2.2 (9) 12 369 1.4 (5) 1.6 (6) 0.8 (3) 13 307 1.3 (4) 0.7 (2) 0.3 (1) 14 217 1.8 (4) 0.92 (2) 0 (0) Total 3015 6.6 (199) 6.1 (185) 2.6 (78) VD: Voiding dysfunction, NE: Nocturnal enuresis Table 2.
Predictors of severity and treatment response in children with
monosymptomatic nocturnal enuresis receiving behavioral therapy.
Monosymptomatic nocturnal enuresis. Dicle Med J 2012;39:145-52.
Monosymptomatic nocturnal enuresis. J Pediatr (Rio J) 2001;77(3):161-168.
Objective: In the treatment of
monosymptomatic nocturnal enuresis (MN E), enuretic alarm devices (EADs) are the first recommended treatment option.
Etiology primary,
monosymptomatic nocturnal enuresis in children.
Treatment of
monosymptomatic nocturnal enuresis by acupuncture: A preliminary study.
Primary
monosymptomatic nocturnal enuresis in children and adolescents.
Family compliance with the use of alarm devices in the treatment of
monosymptomatic nocturnal enuresis. Turkish J Urol 2014;40:52-5.
